Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Acro Biomedical (ACBM) Revenue (2017 - 2022)

Acro Biomedical (ACBM) has 6 years of Revenue data on record, last reported at $360000.0 in Q4 2022.

  • For Q4 2022, Revenue fell 39.8% year-over-year to $360000.0; the TTM value through Sep 2023 reached $360000.0, down 59.84%, while the annual FY2022 figure was $658500.0, 45.01% down from the prior year.
  • Revenue reached $360000.0 in Q4 2022 per ACBM's latest filing, up from $298500.0 in the prior quarter.
  • Across five years, Revenue topped out at $2.4 million in Q3 2018 and bottomed at -$1.2 million in Q4 2019.
  • Average Revenue over 5 years is $775454.8, with a median of $549000.0 recorded in 2021.
  • Peak YoY movement for Revenue: crashed 185.71% in 2019, then surged 200.0% in 2022.
  • A 5-year view of Revenue shows it stood at $1.4 million in 2018, then tumbled by 185.71% to -$1.2 million in 2019, then soared by 159.28% to $687964.0 in 2020, then fell by 13.08% to $598000.0 in 2021, then plummeted by 39.8% to $360000.0 in 2022.
  • Per Business Quant database, its latest 3 readings for Revenue were $360000.0 in Q4 2022, $298500.0 in Q1 2022, and $598000.0 in Q4 2021.